A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy

Resistance to platinum and taxane adjuvant chemotherapy (ACT) is the main cause of the recurrence and poor prognosis of high-grade serous ovarian cancer (HGS-OvCa) patients receiving platinum-taxane ACT after surgery. However, currently reported quantitative transcriptional signatures, which are com...

Full description

Bibliographic Details
Main Authors: Yixin Liu, Zheyang Zhang, Tianhao Li, Xin Li, Sainan Zhang, Ying Li, Wenyuan Zhao, Yunyan Gu, Zheng Guo, Lishuang Qi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
platinum chemotherapy
taxane chemotherapy
predictive signature
relative expression orderings
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01094/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01094/full

Similar Items